Anorexia is a frequent part of uremic syndrome, contributing to malnutrition in dialysis patients. Many factors have been suggested as responsible for uremic anorexia.
In this paper we formulate a new hypothesis to explain the appetite disorders in dialysis patients: “the tryptophan/serotonin disorder hypothesis.” We review current knowledge of normal hunger–satiety cycle control and the disorders described in uremic patients. There are four phases in food intake regulation: (1) the gastric phase, during which food induces satiety through gastric distention and satiety peptide release; (2) the post absorptive phase, during which circulating compounds, including glucose and amino acids, cause satiety by hepatic receptors via the vagus nerve; (3) the hepatic phase, during which adenosine triphosphate (ATP) concentration is the main stimulus inducing hunger or satiety, with cytokines inhibiting ATP production; and (4) the central phase, during which appetite is regulated through peripheral (circulating plasma substances and neurotransmitters) and brain stimuli. Brain serotonin is the final target for peripheral mechanisms controlling appetite. High brain serotonin levels and a lower serotonin/ dopamine ratio cause anorexia. Plasma and brain amino acid concentrations are recognized factors involved in neurotransmitter synthesis and appetite control. Tryptophan is the substrate of serotonin synthesis. High plasma levels of anorectics such as tryptophan (plasma and brain), cholecystokinin, tumor necrosis factor alpha, interleukin-1, and leptin, and deficiencies of nitric oxide and neuropeptide Y have been described in uremia; all increase intracerebral serotonin.
We suggest that brain serotonin hyperproduction due to a uremic-dependent excess of tryptophan may be the final common pathway involved in the genesis of uremic anorexia. Various methods of ameliorating anorexia by decreasing the central effects of serotonin are proposed.
BlumenkrantzM.J.Nutrition. In: DaugirdasJ.T., IngT., eds. Handbook of dialysis, 2nd ed.Chicago, IL: Little Brown, 1995: 79–89.
2.
CianciarusoB., BrunoriG.Malnutrition in patients on CAPD: Aetiology, prevention and management. In: AndreucciV.E., FineL., eds. International yearbook of nephrology.Oxford: Oxford University Press, 1996: 141–50.
3.
BergströmJ.Appetite in CAPD patients.Perit Dial Int1996; 16(Suppl 1): S181–4.
4.
BabbA., FarrellP.C., UvelliD.A., ScribnerB.M.Hemodialyzed evaluation by examination of solute molecular spectra.Trans Am Soc Artif Intern Organs1972; 17: 98–105.
5.
LindsayR.M., SpannerE.A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients.Am J Kidney Dis1989; 13: 382–9.
6.
AnderstamB., MamounA.H., SöderstenP., BergströmJ.Middle-sized molecules fraction from uremic ultra-filtrate (UF) and normal urine inhibit ingestive behavior in the rat.J Am Soc Nephrol1996; 7: 2453–60.
7.
MarcusR.G., CohnE., UribarriJ.Middle molecule clearance does not influence protein intake in hemodialysis patients.Am J Kidney Dis1998; 31: 491–4.
8.
KeshaviahP.R., NolphK.D., Van StoneJ.C.The peak concentration hypothesis: A urea kinetic approach to comparing the adequacy of continuous ambulatory peritoneal dialysis (CAPD) and hemodialysis.Perit Dial Int1989; 9: 257–60.
9.
HeimbürgerO., TranæusA., BergströmJ., LindholmB.The effect of increased PD on Kt/V; protein catabolic rate (PCR) and serum albumin.Perit Dial Int1992; 12(Suppl): S19.
10.
HartyJ., FaragherB., VenningM., GokalR.Urea kinetic modeling exaggerates the relationship between nutrition and dialysis in CAPD patients (the hazards of cross-selectional analysis).Perit Dial Int1995; 5: 105–9.
11.
BrayG.A.Genetic and hypothalamic mechanisms for obesity — finding the needle in the haystack.Am J Clin Nutr1989; 50: 891–902.
12.
Uvnäs–MobergK.Endocrinologic control of food intake.Nutr Rev1990; 48: 57–63.
13.
YorkD.A.Metabolic regulation of food intake.Nutr Rev1990; 48: 64–70.
14.
StrickerE.M.Biological bases of hunger and satiety: Therapeutic implications.Nutr Rev1984; 42: 333–40.
15.
PeikinS.R.Role of cholecystokinin in the control of food intake.Gastroenterol Clin North Am1989; 18: 757–75.
16.
AndersonG.H., LuoS., NgL.T., LiE.T.S.Non-essential amino acids and short-term food intake of the rats.Life Sci1994; 14: 1179–89.
17.
AndersonG.H., LiE.T.S., AnthonyS.P., NgL.T., BialikR.Dissociation between plasma and brain amino acid profiles and short-term food intake in the rat.Am J Physiol1994; 35: R1675–86.
18.
MayerJ.Regulation of energy intake and the body weight: The glucostatic theory and the lipostatic hypothesis.Ann N Y Acad Sci1955; 63: 15–43.
19.
MellinkoffS.M., FranklandM., BoyleD., GreipelM.Relationship between serum amino acids concentration and fluctuation in appetite.J Appl Physiol1956; 8: 535–8.
20.
BalaskasE.V., RodelaH., OreopoulosD.G.Effects of intraperitoneal infusion of dextrose and amino acids on the appetite of rabbits.Perit Dial Int1993; 13(Suppl 2): S490–8.
21.
MamounA.H., AnderstamB., SöderstenP., LindholmB., BergströmJ.Influence of peritoneal dialysis solutions with glucose and amino acids on ingestive behavior in rat.Kidney Int1996; 49: 1276–82.
22.
FriedmanA.Control of energy intake by energy metabolism.Am J Clin Nutr1995; 62(Suppl 5): S1095–100.
23.
BellingerL.L., WilliamsF.E., RogersQ.R., GietzenD.W.Liver denervation attenuates the hypophagia produced by an imbalanced acid diet.Physiol Behav1996; 59: 925–9.
24.
ModawerL.L., AndersonC., GelinJ., LundholmK.G.Regulation of food intake and hepatic protein synthesis by recombinant derivated cytokines.Am J Physiol1988; 254: G450–6.
25.
DubeM.G., XuB., CrowleyW.R., KalraP.S., KarlaS.P.Evidence that neuropeptide Y is a physiological signal of normal food intake.Brain Res1994; 646: 341–4.
26.
MorleyJ.E.Neuropeptide regulation of appetite and weight.Endocr Rev1987; 8: 256–87.
27.
Plata–SalamánC.Cytokines and feeding suppression: An integrative view from neurologic to molecular levels.Nutrition1995; 11(Suppl 5): S674–7.
28.
KapásL., HongL., CadyA.B., OppM.R., PostlethwaiteA.E., SeyerJ.M.Somnogenic, pyrogenic, and anorectic activities of tumor necrosis factor alpha and TNF-α fragments.Am J Physiol1993; 263: R708–15.
29.
DaunJ.M., McCarthyD.O.The role of cholecystokinin in interleukin-1-induced anorexia.Physiol Behav1993; 54: 237–41.
30.
TregetE.E., YuY.M., ZhongS., BuriniR., OkusawaS., GelfandJ.A.Role of interleukin 1 and tumor necrosis factor on energy metabolism in rabbits.Am J Physiol1988; 255: E760–8.
31.
JeanningrosR.Vagal unitary responses to intestinal amino acid infusions in the anaesthetized cat: A putative signal for protein induced satiety.Physiol Behav1982; 28: 9.
32.
CangianoC., LavianoA., MuscaritoliM., MeguidM.M., CascinoA., FanelliF.R.Cancer anorexia: New pathogenic and therapeutic insights.Nutrition1996; 12(Suppl 1): S48–50.
33.
BeverlyJ.L., HrupkaB.J., GietzenD.W., RogersQ.R.Timing and dose of amino acids injected into the prepyriform cortex influence food intake.Physiol Behav1993; 53: 899–903.
34.
MorleyJ.E., FloodJ.F.Competitive antagonism of nitric oxide synthetase causes weight loss in mice.Life Sci1992; 51: 1285–9.
SquadritoF., CalapaiD., AltavillaD., CucinottaB., ZingarelltG.M., CampoV.Central serotoninergic system involvement in the anorexia induced by NG-nitro-L-arginine, an inhibitor of nitric oxide synthase.Eur J Pharmacol1994; 255: 51–5.
37.
KuhnD.M., ArthurR.Molecular mechanism of the inactivation of tryptophan hydroxilase by nitric oxide: Attack on critical sulfhydryls that spare the enzyme iron center.J Neurosci1997; 17: 7245–51.
38.
DunnA.J.Brain catecholaminergic and tryptophan responses to restraint are attenuated by nitric oxide synthase inhibition.Neurochem Int1998; 33: 551–7.
39.
RitzE., VillanceP., NowickiM.The effect of malnutrition on cardiovascular mortality in dialysis patients: Is L-arginine the answer?Nephrol Dial Transplant1994; 9: 129–30.
40.
HeidbrederE., SchafferhansK., HeidlandA.Disturbances of peripheral and autonomic nervous system in chronic renal failure: Effects of hemodialysis and transplant.Clin Nephrol1985; 23: 222–8.
41.
RavelliA.M., LedermannS.E., BissetW.M., TrompeterR.S., BarrattT.M., MillaP.J.Foregut motor function in chronic renal failure.Arch Dis Child1992; 67: 1343–7.
42.
PereiraB.J.G., ShapiroL., KingA.J., FalagasM.E., StromJ.A., DinarelloC.A.Plasma levels of IL-1β, TNF-α and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients.Kidney Int1994; 45: 890–6.
43.
AremR.Hypoglycemia associated with renal failure.Endocrinol Metab Clin North Am1989; 18: 103–21.
44.
VallanceP., LeoneA., CalverA., CollierJ., MoncadaS.Accumulation of an endogenous inhibitor nitric oxide synthesis in chronic renal failure.Lancet1992; 339: 572–5.
45.
StenvinkelP.Leptin — a new hormone of definite interest for the nephrologist.Nephrol Dial Transplant1998; 13: 1099–101.
46.
FantinoM., WieteskaL.Evidence for a direct central anorectic effect of tumor necrosis alpha in the rat.Physiol Behav1993; 33: 477–83.
47.
BuenoL., FioramontiJ.Neurohormonal control of intestinal transit.Reprod Nutr Dev1994; 34: 513–18.
48.
HsuW.A., LeeK.C., LinS.L., LeeS.H., HsiehS.J., KanY.T.Clinical manifestations of trace metal abnormality in hemodialysis patients: A multicenter collaborative study.Dial Transplant1997; 26: 15–20.
49.
SchreiberM.Can malnutrition be prevented?Perit Dial Int1995; 15(5, Suppl): S39–49.
50.
AguileraA., CodoceoR., SelgasR., GarcíaP., PicornellM., DíazC.Anorexigen (TNF-α, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: Their relationship with nutritional parameters.Nephrol Dial Transplant1998; 13: 1476–83.
MeguidM.M., YangZ.J., GleasonJ.R.The gut–brain brain–gut axis on anorexia: Toward an understanding of food intake regulation.Nutrition1996; 12(Suppl 1): S57–62.
53.
BrennerD., BuckM., FeitelbergS., ChojkierM.Tumor necrosis factor alpha inhibits albumin gene expression in a murine model of cachexia.J Clin Invest1990; 85: 248–55.
54.
NishidaK., HarrisonD.G., NavasJ.P., FisherA.A., DockeryS.P., UematsuM.Molecular cloning and characterization of the constitutive bovine aortic endothelial cell nitric oxide synthase.J Clin Invest1992; 90: 2092–6.
55.
AndoT., DunnA.J.Mouse tumor necrosis factor alpha increases brain tryptophan concentrations and norepinephrine metabolism while activating the HPA axis in mice.Neuroimmunomodulation1999; 6: 319–29.
56.
AguileraA., BajoM.A., SelgasR., RebolloF., RocaA., DíezJ.J.Plasma leptin levels in peritoneal dialysis (PD) patients: Its relation with nutritional status, anorexia and obesity (Abstract).J Am Soc Nephrol1997; 8: 260A.
57.
ConverseRl, JacobsenT.N., TotoR.D., JostC.M.T., CosentinoF., Fouad–TaraziF.Sympathetic over-activity in patients with chronic renal failure.N Engl J Med1992; 327: 1912–18.
58.
IsseT., UetaY., SerinoR., NoguchiJ., YamamotoY., NomuraM.Effects of leptin on fasting-induced inhibition of neural nitric oxide synthase mRNA in paraventricular and supraoptic nuclei of rats.Brain Res1999; 846: 229–35.
59.
CalapaiG., CoricaF., CorsonelloA., SautebinL., Di RosaM., CampoG.M.Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis.J Clin Invest1999; 104: 975–82.
60.
LavianoA., MeguidM.M., YangZ-J, GleasonJ.R., CancianoC., FanelliR.F.Cracking the riddle of cancer anorexia.Nutrition1996; 12: 706–10.
61.
HochwaldS.N., HarrisonL.E., PortJ.L., BlumbergD., BrennanM.F., BurtM.Depletion of high energy phosphate compounds in the tumor-bearing state and reversal after tumor resection.Surgery1996; 120: 534–41.
62.
CangianoC., LavianoA., MeguidM.M., MulieriM., ConversanoL., PreziosaI.Effects of administration of oral branched-chain amino acids on anorexia and caloric intake in cancer patients.J Natl Cancer Inst1996; 88: 550–2.
63.
MuscaritoliM., MeguidM.M., BeverlyJ.L., YangZ.J., CangianoC., Rossi–FanelliF.Mechanism of early tumor anorexia.J Surg Res1996; 60: 389–97.
64.
LindholmB., AlverstrandA., FürstP., BergtrömJ.Plasma and muscle amino acids during continuous ambulatory peritoneal dialysis.Kidney Int1989; 35: 1219–26.
65.
LavianoA., CangianoC., PreziosaI., RiggioO., ConversanoL., CascinoA.Plasma tryptophan and anorexia in liver cirrhosis.Int J Eat Disord1996; 21: 181–6.
66.
SiassiF., WangM., KoppleJ.D., SwendseidM.E.Plasma tryptophan levels and brain serotonin metabolism in chronically uremic rats.J Nutr1977; 107: 840–5.
67.
LeibowitzS.F., AlexanderJ.T.Hypothalamic serotonin in control of eating behavior, meal size, and body weight.Biol Psychiatry1998; 44: 851–64.
68.
CasperR.C.Serotonin, a major player in the regulation of feeding and affect.Biol Psychiatry1998; 44: 795–7.
69.
SullivanP.A., MurnaghanD., CallaghanN., KantamanemiB.D., CurzonG.D.Cerebral transmitter precursors and metabolites in advanced renal disease.J Neural Neurosurg Psychiatry1978; 41: 581–8.
70.
ChengC-H, ChengF-C, ShuK-H, WuM-J. Abnormal serotonin metabolism in long-term hemodialysis and CAPD patients.Am J Nephrol1997; 17: 541–2.
71.
KayeW., GendallK., StroberM.Serotonin neuronal function and selective serotonin reuptake inhibitor treatment in anorexia and bulimia nervosa.Biol Psychiatry1998; 44: 825–38.
